StemSave, Inc. Moves Corporate Headquarters to New York City

StemSave(TM), Inc., a market leader in the field of stem cell recovery and cryo-preservation, announced today that effective immediately, it is moving its corporate headquarters to New York City (its lab and cryo-preservation facilities will remain in Massachusetts). Arthur E. Greco, CEO, made the announcement today from the company’s new offices in Manhattan. “Not only does this move bring our corporate offices closer to our scientific advisors, it places us in one of the global epicenters of stem cell research. In addition, it allows us to participate in New York State’s $600 million stem cell research initiative. This is an enormous opportunity for us and for the families we serve.” StemSave’s scientific advisory council includes Dr. Jeremy Mao, DDS, PhD, a Director of the Tissue Engineering and Regenerative Medicine Laboratory (TERML) and a Professor at Columbia University, and Gordana Vunjak-Novakovic, PhD, a Director of the Laboratory for Stem Cells and Tissue Engineering and Professor of Biomedical Engineering at Columbia University.

Stem Cells’ Value to Potential Therapies

Stem cells are unique in that they are the only cells in the body that can regenerate and differentiate into specialized cell types. Hence, they drive the body’s natural healing and maintenance processes. Researchers at the National Institutes of Health have discovered powerful adult stem cells in the dental pulp of baby teeth, impacted wisdom teeth and healthy permanent teeth. Ongoing medical research demonstrates that stem cells from teeth are particularly ‘plastic’ — that is, they can be manipulated to grow into many different cell types such as, bone, muscle, cartilage, skin, neural tissue and cells that make up vital organs. Given their unique properties, stem cells have the potential to treat disease and injuries contemporary medicine deems difficult, if not impossible, to treat with current methods. Medical researchers around the world are working today to develop powerful new treatments from stem cells for a wide range of diseases and injuries such as diabetes, Parkinson’s, muscular dystrophy, heart failure, bone regeneration, joint replacement, brain trauma, infertility, arthritis, osteoporosis and Crohn’s disease.

“StemSave is a unique collaboration between top stem cell researchers and the dental community to develop a safe, affordable, and simple way for patients — young and old — to collect and preserve their stem cells,” said Greco. “Most people are already aware of the benefits of saving highly-valued cells today for future use; they’ve been doing so for years with eggs, sperm, and umbilical cord blood. Now, after the discovery of powerful stem cells in teeth, StemSave offers families the opportunity to benefit from their own stem cells as new stem cell based regenerative and personalized medical treatments are developed. What’s so unique about banking dental stem cells is that the procedure requires nothing more from the patient than what would have happened at the dentist anyway, when a tooth gets extracted.”

StemSave has established an expanding network of dentists nationwide offering its service to patients throughout the country. “Dentists are particularly excited to be a part of this,” said Greco. “They understand that regenerative and personalized medical treatments are the future direction of medicine.”

About StemSave, Inc.

StemSave provides an affordable and non-invasive method for the recovery and cryo-preservation of the powerful Adult Stem Cells found in teeth by teaming up with dentists to harvest stem cells during routine dental procedures.

 Press Inquiries: Meir Kahtan Public Relations, LLC 212-669-6065 Email Contact  StemSave, Inc. Arthur E. Greco 917.699.0155 Email Contact

SOURCE: StemSave